Leukemia - Acute Lymphocytic (ALL) in Adults

FDA Approves Blincyto for a Type of Acute Lymphoblastic Leukemia (ALL)

The US Food and Drug Administration (FDA) has approved Blincyto (blinatumomab) to treat Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (ALL).

Manufacturer Halts Sales of Leukemia Drug Iclusig

Ariad Pharmaceuticals has suspended sales of the chemotherapy drug Iclusig (ponatinib), which is used to treat chronic myeloid leukemia (CML) and some forms of acute lymphocytic leukemia (ALL).